13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002056052
Total reported value
$333.8M
$333.8M
179 檔
7.8%
The Q2 2025 SEC filing reveals that Persistent Asset Partners Ltd held a total portfolio value of $333.8M, covering 179 public equity positions.
During Q2 2025, Persistent Asset Partners Ltd's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 4.40% | -0.01% | EXIT | |
| 2 | ✓ | Capricor Therapeutics Inc | Stock-Other | 4.07% | — | — | |
| 3 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 4.06% | — | +204.93% | |
| 4 | HUM | Humana Inc | Stock-Healthcare | 3.64% | -0.11% | EXIT | |
| 5 | PNTG | Pennant Group Inc/the | Stock-Other | 3.10% | — | -17.32% | |
| 6 | EHC | Encompass Health CORP | Stock-Healthcare | 2.66% | +0.01% | NEW | |
| 7 | AMGN | Amgen Inc | Stock-Healthcare | 2.49% | +0.01% | NEW | |
| 8 | ✓ | Corcept Therapeutics Inc | Stock-Other | 2.46% | — | +37000.58% | |
| 9 | ALHC | Alignment Healthcare Inc | Stock-Other | 2.37% | — | -13.66% | |
| 10 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 2.28% | -0.65% | +137.25% | |
| 11 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 2.02% | +0.02% | NEW | |
| 12 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.97% | -0.62% | -23.64% | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.89% | -1.04% | +20.00% | |
| 14 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 1.81% | +0.58% | +266.33% | |
| 15 | CAH | Cardinal Health Inc | Stock-Healthcare | 1.69% | — | NEW | |
| 16 | THC | Tenet Healthcare CORP | Stock-Healthcare | 1.63% | +0.08% | NEW | |
| 17 | EHABUSD | Enhabit Inc | Stock-Other | 1.47% | — | -28.26% | |
| 18 | NXE | Nexgen Energy LTD | Stock-Other | 1.43% | -0.39% | +7.52% | |
| 19 | CNOB | Connectone Bancorp Inc | Stock-Other | 1.41% | -0.12% | EXIT | |
| 20 | 2655957D | Premier Inc-class A | Stock-Other | 1.33% | — | — | |
| 21 | EVH | Evolent Health Inc - A | Stock-Other | 1.30% | — | — | |
| 22 | ETHA | Ishares Ethereum Trust ETF | ETF-Other | 1.22% | — | — | |
| 23 | CCB | Coastal Financial Corp/wa | Stock-Other | 1.18% | -0.70% | EXIT | |
| 24 | PCVX | Vaxcyte Inc | Stock-Other | 1.10% | +0.11% | +115.24% | |
| 25 | ✓ | Moonlake Immunotherapeutics | Stock-Other | 1.10% | — | — | |
| 26 | DGX | Quest Diagnostics Inc | Stock-Healthcare | 1.07% | +0.03% | NEW | |
| 27 | AX | Axos Financial Inc | Stock-Financials | 1.06% | -0.74% | EXIT | |
| 28 | SEM | Select Medical Holdings CORP | Stock-Other | 1.05% | — | — | |
| 29 | C | Citigroup Inc | Stock-Financials | 1.04% | -0.35% | -21.49% | |
| 30 | ✓ | Pagaya Technologies LTD Cl | Stock-Other | 1.00% | — | — | |
| 31 | HBM | Hudbay Minerals Inc | Stock-Other | 0.97% | +0.42% | NEW | |
| 32 | LH | Labcorp Holdings Inc | Stock-Healthcare | 0.92% | — | — | |
| 33 | FUTU | Futu Holdings Ltd-adr | Stock-Financials | 0.92% | — | — | |
| 34 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.89% | -0.25% | +89.75% | |
| 35 | MRNA | Moderna, Inc. | Stock-Healthcare | 0.89% | — | +19674.78% | |
| 36 | CI | THE Cigna Group | Stock-Healthcare | 0.89% | — | — | |
| 37 | AA | Alcoa CORP | Stock-Materials | 0.86% | +0.12% | NEW | |
| 38 | ✓ | Mereo Biopharma Group PLC | Stock-Other | 0.76% | — | +2430.77% | |
| 39 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.76% | -0.17% | EXIT | |
| 40 | EGO | Eldorado Gold CORP | Stock-Other | 0.74% | -0.05% | -24.06% | |
| 41 | UMBF | Umb Financial CORP | Stock-Financials | 0.73% | -0.12% | EXIT | |
| 42 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.72% | — | — | |
| 43 | CRH | CRH plc | Stock-Materials | 0.72% | -0.19% | +9.55% | |
| 44 | AMGN | Amgen Inc. | Stock-Healthcare | 0.68% | — | +549410.83% | |
| 45 | BAC | Bank Of America CORP | Stock-Financials | 0.66% | — | — | |
| 46 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 0.65% | — | -46.71% | |
| 47 | SSBUSD | Southstate Bank CORP | Stock-Other | 0.64% | — | -45.86% | |
| 48 | EQX | Equinox Gold CORP | Stock-Other | 0.63% | -0.29% | +95.37% | |
| 49 | RKT | Rocket Cos Inc-class A | Stock-Financials | 0.62% | -0.36% | EXIT | |
| 50 | COIN | Coinbase Global Inc -class A | Stock-Financials | 0.61% | -0.03% | — |
According to official SEC Form 13F filings, Persistent Asset Partners Ltd reported a total U.S. public equity portfolio value of $333.8M across 179 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IBIT, CAPRICOR THERAPEUTICS INC, SLNOEUR) accounted for 7.8% of total reported equity market value during Q2 2025.
During Q2 2025, Persistent Asset Partners Ltd's top holdings by market value included IBIT (4.4%)、CAPRICOR THERAPEUTICS INC (4.1%)、SLNOEUR (4.1%). The largest single position, IBIT, represented 4.4% of total portfolio value.
In Q2 2025, Persistent Asset Partners Ltd made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.